L. Perez

发表

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

S. Rowland-Jones, D. Montefiori, J. Theiler, 2020, Cell.

Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin

John P. Moore, I. Wilson, M. Nussenzweig, 2019, Journal of Virology.

Epitopes Immediately below the Base of the V3 Loop of gp120 as Targets for the Initial Autologous Neutralizing Antibody Response in Two HIV-1 Subtype B-Infected Individuals

E. Rosenberg, B. Korber, H. Liao, 2011, Journal of Virology.

Antibody-Dependent, FcγRI-Mediated Neutralization of HIV-1 in TZM-bl Cells Occurs Independently of Phagocytosis

S. Zolla-Pazner, D. Montefiori, L. Perez, 2013, Journal of Virology.

Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41

B. Haynes, D. Montefiori, L. Perez, 2009, Journal of Virology.

Expression of the Rous sarcoma virus env gene from a simian virus 40 late-region replacement vector: effects of upstream initiation codons

E. Hunter, J. Wills, L. Perez, 1987, Journal of virology.

Envelope Glycoprotein Binding to the Integrin (cid:2) 4 (cid:3) 7 Is Not a General Property of Most HIV-1 Strains

Haiyan Chen, H. Liao, D. Montefiori, 2014 .

Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.

X. Daniell, J. Kappes, D. Montefiori, 2014, Journal of immunological methods.

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Allan C. deCamp, Jerome H. Kim, D. Montefiori, 2017, PloS one.

The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates

C. Woods, Laura L. Sutherland, B. Haynes, 2021, bioRxiv.

Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage

E. Hunter, J. Dong, L. Perez, 1992, Journal of virology.

Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions

G. Davis, E. Hunter, L. Perez, 1987, Journal of virology.

Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37

E. Hunter, L. Perez, 1987, Journal of virology.

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

C. Woods, Laura L. Sutherland, B. Haynes, 2021, Cell.

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

T. Kepler, M. Borgnia, B. Korber, 2019, PLoS pathogens.

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies

Tongqing Zhou, Hongmei Gao, David C Montefiori, 2018, PLoS pathogens.

The transmembrane glycoprotein of human immunodeficiency virus type 1 induces syncytium formation in the absence of the receptor binding glycoprotein

M. O'Donnell, L. Perez, E. Stephens, 1992, Journal of virology.

Envelope Glycoprotein Binding to the Integrin α4β7 Is Not a General Property of Most HIV-1 Strains

Hua-Xin Liao, David C. Montefiori, Haiyan Chen, 2014, Journal of Virology.

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

T. Kepler, M. Borgnia, B. Korber, 2019, PLoS pathogens.

Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1

T. Hope, D. Montefiori, M. Tay, 2019, Journal of Virology.

The Entire SU Subunit is Required for the Incorporation of the HIV-1 Envelope Glycoprotein Complex into Virions

L. Perez, Ying-Ying Li, 2004, Virus Genes.

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Allan C. deCamp, Jerome H. Kim, D. Montefiori, 2017, PloS one.